Aneurysmal subarachnoid hemorrhage (aSAH) results in low prevalence of neuro-endocrine dysfunction and NOT deficiency

Pituitary

Volumn 15, Issue 4, 2012, Pages 505-512

  Lammert, Alexander ^a   Bode, Hinrich ^a   Hammes, Hans Peter ^a   Birck, Rainer ^a   Fatar, Marc ^a   Zohsel, Katrin ^a   Schmieder, Kirsten ^a   Schubert, Gerrit Alexander ^b   Thomé, Claudius ^b   Seiz, Marcel ^b,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Aneurysmal subarachnoid hemorrhage; Glasgow outcome scale; Neuro endocrine dysfunction; Neuropsychological deficits

Indexed keywords

CORTICOTROPIN; ESTRADIOL; FOLLITROPIN; GROWTH HORMONE; HYDROCORTISONE; LUTEINIZING HORMONE; PROLACTIN; SOMATOMEDIN C; TESTOSTERONE;

ADULT; AMENORRHEA; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; CONCENTRATION; CONTROLLED STUDY; DEPTH PERCEPTION; DISEASE ASSOCIATION; FEMALE; FIGURAL MEMORY; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHYROIDISM; INCIDENCE; MALE; MEMORY; MENTAL FUNCTION; NEUROENDOCRINE DEFICIENCY; NEUROENDOCRINE DISEASE; NEUROENDOCRINE DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RISK ASSESSMENT; RISK FACTOR; SHORT TERM MEMORY; SUBARACHNOID HEMORRHAGE; VERBAL BEHAVIOR; WORKING MEMORY;

ADRENOCORTICOTROPIC HORMONE; ADULT; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYPOTHYROIDISM; INSULIN-LIKE GROWTH FACTOR I; LUTEINIZING HORMONE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROLACTIN; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TESTOSTERONE;

EID: 84870347901     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-011-0357-5     Document Type: Article

References (24)

1. Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner JE Jr, Harbaugh RE, Patel AB, Rosenwasser RH (2009) American Heart Association 2009 guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40: 994-1025
2. Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, Sandercock P, for the International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group (2005) International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 366: 809-817
3. Ogden JA, Mee EW, Henning M (1993) A prospective study of impairment of cognition and memory and recovery after subarachnoid hemorrhage. Neurosurgery 33: 572-586
4. Berry E, Jones RA, West CG, Brown JD (1997) Outcome of subarachnoid haemorrhage. An analysis of surgical variables, cognitive and emotional sequelae related to SPECT scanning. Br J Neurosurg 11: 378-387
5. Bellebaum C, Schäfers L, Schoch B, Wanke I, Stolke D, Forsting M, Daum I (2004) Clipping versus coiling: neuropsychological follow up after aneurysmal subarachnoid haemorrhage (SAH). J Clin Exp Neuropsychol 26: 1081-1092
6. Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A (2007) Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage. A systematic review. JAMA 298: 1429-1438
7. Kreitschmann-Andermahr I, Hoff C, Saller B, Niggemeier S, Pruemper S, Hütter BO, Rohde V, Gressner A, Matern S, Gilsbach JM (2004) Prevalence of pituitary deficiency in patients after aneurysmal subarachnoid hemorrhage. J Clin Endocrinol Metab 89: 4986-4992
8. Dimopoulou I, Kouyialis AT, Tzanella M, Armaganidis A, Thalassinos N, Sakas DE, Tsagarakis S (2004) High incidence of neuroendocrine dysfunction in long-term survivors of aneurysmal subarachnoid hemorrhage. Stroke 35: 2884-2889
9. Aimaretti G, Ambrosio MR, Di Somma C, Gasperi M, Cannavò S, Si C, Fusco A, Del Monte P, De Menis E, Faustini- Fustini M, Grimaldi F, Logoluso F, Razzore P, Rovere S, Benvenga S, Degli Uberti EC, De Marinis L, Lombardi G, Mantero F, Martino E, Giordano G, Ghigo E (2005) Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. J Clin Endocrinol Metab 90: 6085-6092
10. Aimaretti G, Ambrosio MR, Di Somma C, Fusco A, Cannavò S, Gasperi M, Si C, De Marinis L, Benvenga S, degli Uberti EC, Lombardi G, Mantero F, Martino E, Giordano G, Ghigo E (2004) Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin Endocrinol 61: 320-326
11. Lammert A, Bode H, Hammes HP, Birck R, Fatar M, Zohsel K, Braun J, Schmieder K, Diepers M, Schubert GA, Barth M, Thomé C, Seiz M (2011) Neuro-endocrine and neuropsychological outcome after aneurysmal subarachnoid hemorrhage (aSAH): a prospective cohort study. Exp Clin Endocrinol Diabetes 119: 111-116
12. Lindholm J, Kehlet H (1987) Re-evaluation of the clinical value of the 30 min ACTH test in assessing the hypothalamic-pituitaryadrenocortical function. Clin Endocrinol 26: 53-59
13. GH Research Society (2000) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH research society. J Clin Endocrinol Metab 85: 3990-3993
14. Sievers C, Brübach K, Saller B, Schneider HJ, Buchfelder M, Droste M, Mann K, Strasburger CJ, Stalla GK, On behalf of the German Pegvisomant Investigators (2010) Change of symptoms and perceived health in acromegalic patients on pegvisomant therapy: a retrospective cohort study within the German pegvisomant observational study (GPOS). Clin Endocrinol (Oxf) 73: 89-94
15. Vanhorebeek I, Langouche L, Van den Berghe G (2006) Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab 2: 20-31
16. Bidlingmaier M (2009) Pitfalls of insulin-like growth factor I assays. Horm Res 1: 30-33
17. Kokshoorn N, Wassenaar M, Biermasz N, Roelfsema F, Smit J, Romijn J, Pereira A (2010) Hypopituitarism following traumatic brain injury: the prevalence is affected by the use of different dynamic tests and different normal values. Eur J Endocrinol 162: 11-18
18. Bendel S, Koivisto T, Ryynänen OP, Ruokonen E, Romppanen J, Kiviniemi V, Uusaro A (2010) Insulin like growth factor-I in acute subarachnoid hemorrhage: a prospective cohort study. Crit Care 14:R75
19. Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A (1994) Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 25: 1342-1347
20. Hop JW, Rinkel GJ, Algra A, van Gijn J (1997) Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 28: 660-664
21. Tanriverdi F, Dagli AT, Karaca Z, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F (2007) High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: a prospective investigation of anterior pituitary function in the acute phase and 12 months after the event. Clin Endocrinol (Oxf) 67: 931-937
22. Jovanovic V, Pekic S, Stojanovic M, Tasic G, Djurovic B, Soldatovic I, Doknic M, Miljic D, Djurovic M, Medic-Stojanoska M, Popovic V (2010) Neuroendocrine dysfunction in patients recovering from subarachnoid hemorrhage. Hormones (Athens) 9: 235-244
23. Klose M, Brennum J, Poulsgaard L, Kosteljanetz M, Wagner A, Feldt-Rasmussen U (2010) Hypopituitarism is uncommon after aneurysmal subarachnoid haemorrhage. Clin Endocrinol 73: 95-101
24. van der Eerden AW, Twickler MT, Sweep FC, Beems T, Hendricks HT, Hermus AR, Vos PE (2010) Should anterior pituitary function be tested during follow-up of all patients presenting at the emergency department because of traumatic brain injury? Eur J Endocrinol 162: 19-28